Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies
about
Cannabinoid type 1 receptor antagonists for smoking cessationClinical correlates of co-occurring cannabis and tobacco use: a systematic reviewNicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251Terpenes and lipids of the endocannabinoid and transient-receptor-potential-channel biosignaling systemsUnderstanding the mechanisms of human tubal ectopic pregnancies: new evidence from knockout mouse modelsThe cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in miceAM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking.Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptorsA common haplotype in NAPEPLD is associated with severe obesity in a Norwegian population-based cohort (the HUNT study).Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial.Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferencesPrior exposure to THC increases the addictive effects of nicotine in rats.The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail.Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptorsRole of the endogenous cannabinoid system in nicotine addiction: novel insights.The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intakeDiacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure.Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists.Current and emerging pharmacotherapeutic options for smoking cessation.Mechanism-based medication development for the treatment of nicotine dependence.Antagonist-elicited cannabis withdrawal in humansEffects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats.The future of endocannabinoid-oriented clinical research after CB1 antagonists.The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.High on habits.Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence.Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approach.Pharmacotherapy for smoking cessation: current advances and research topics.CB1 receptor antagonists: new discoveries leading to new perspectives.Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.Cannabinoid receptor CB1 is involved in nicotine-induced protection against Aβ1-42 neurotoxicity in HT22 cells.Medical marijuana legalization and cigarette and marijuana co-use in adolescents and adults.THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction.The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area.Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor.Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
P2860
Q24235611-BA32E207-8D2D-4AFA-9E51-73F61F7E8EB7Q24602357-17186FA9-7D2D-43B7-B901-8EFA17D6C590Q28564481-AE73C213-5EA9-40BB-B080-EDDBBEF18255Q28829964-6F30B785-34E9-45E4-AB6F-E1A4665C5BA2Q33634054-A36385AC-CFFC-4018-8E8A-E8C05A6EDC65Q33703839-CC96BA46-8E63-49F3-937F-DD1C1687E8EEQ33759649-8904FD18-6C6B-4D1E-BBE4-1D669AA076C9Q34098179-DB13FDCB-7BBB-485A-8699-A2B5042F1531Q34098252-06E22159-0845-44C4-A44B-149AA5EA8D0AQ34141083-8599554D-33AC-4825-BBA1-503DB91768E8Q34244610-D7E8F421-8BD1-42F2-9BAE-7C23D42E0693Q34318345-F7125396-B08B-4374-9CFC-F5C91181E0A5Q34322263-4630C164-9BD3-4246-8786-27A946A42340Q34663357-A38D2310-CDE9-4D5A-BB81-7699142B7413Q35202878-970FE59C-B594-44FB-AC8F-1F71B00097BCQ35216481-C45315D4-5F82-4642-AF45-81D71EA249E9Q35593066-3985A428-6A25-4ADF-A8AD-571798B90B2BQ36551555-B3F63C30-6F88-4445-BF19-0151887B90B1Q36642428-49D58D8E-2BB4-4F6C-AFEE-4CFDDCDEFE79Q36891273-FDC55584-111C-4407-A11B-260183E7D3CEQ37018610-257D590A-E3FA-4B9A-8751-789A502AA114Q37029517-9A7216C2-C198-425D-83A9-140671E9311BQ37185374-9C849706-0D0D-4EF2-A57D-0E40FB8A9A66Q37226111-1ECBD996-F8BF-419C-80D7-BF155BD9C34FQ37291517-4774ABCB-9E41-4BBA-AA00-5EA408F33860Q37395798-7B49E318-7D37-430B-93A5-0E35782EE078Q37398130-A0FEA2C1-C204-4632-8157-1FEE4F37C0F1Q37728629-06B8C87D-058C-4CD6-9D52-AAB6468F76ADQ37863092-AF858189-C408-4F96-A327-EF6CEB161D81Q37998561-8297833A-B195-464E-9220-2F354E320247Q38636791-5188701F-04AE-4270-AD06-41A632854808Q38686274-24DDB522-7D45-46DF-9720-43CBF49B8FD5Q38952721-8F844C05-6030-41E9-A47E-F4DF2EE8149AQ39557460-8D9BFAE8-D286-4771-9FD5-710558A5CF6DQ41489097-74F33F59-4D7B-4BC4-A861-4915892A8385Q41967071-E8A0071B-5FFE-4E8E-8527-1F40660D29C4Q45300313-779BA5F0-18D8-4EC5-B321-2B023B89F3AFQ48139928-4D921200-E723-4C27-B2CE-1E70F37AB140Q50534434-AD78E785-9C83-4676-A525-581E610E42C1
P2860
Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blocking cannabinoid CB1 recep ...... -clinical and clinical studies
@en
Blocking cannabinoid CB1 recep ...... clinical and clinical studies.
@nl
type
label
Blocking cannabinoid CB1 recep ...... -clinical and clinical studies
@en
Blocking cannabinoid CB1 recep ...... clinical and clinical studies.
@nl
prefLabel
Blocking cannabinoid CB1 recep ...... -clinical and clinical studies
@en
Blocking cannabinoid CB1 recep ...... clinical and clinical studies.
@nl
P2093
P2860
P921
P1433
P1476
Blocking cannabinoid CB1 recep ...... -clinical and clinical studies
@en
P2093
Benoit Forget
Henri-Jean Aubin
Steven R Goldberg
P2860
P304
P356
10.1111/J.1369-1600.2008.00113.X
P577
2008-06-01T00:00:00Z